Huandong Lin
- Epidemiology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Physiology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Topics
- Liver Disease Diagnosis and Treatment (19 papers)Diet, Metabolism, and Disease (9 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Huandong Lin
65 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Epidemiology 467
- Endocrinology, Diabetes and Metabolism 336
- Physiology 258
- Cardiology and Cardiovascular Medicine 216
- Molecular Biology 198
Countries citing papers authored by Huandong Lin
This map shows the geographic impact of Huandong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huandong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huandong Lin more than expected).
Fields of papers citing papers by Huandong Lin
This network shows the impact of papers produced by Huandong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huandong Lin. The network helps show where Huandong Lin may publish in the future.
Co-authorship network of co-authors of Huandong Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Huandong Lin. A scholar is included among the top collaborators of Huandong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huandong Lin. Huandong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 9 | |
| 12 | 37 | |
| 13 | 9 | |
| 14 | 164 | |
| 15 | 8 | |
| 16 | 71 | |
| 17 | 9 | |
| 18 | 21 | |
| 19 | 3 | |
| 20 | [The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study]. | 2 |
About Huandong Lin
Huandong Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Epidemiology, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Diet, Metabolism, and Disease (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (336 citations), Epidemiology (467 citations) and Hepatology (90 citations). Huandong Lin has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Xin Gao, Mingfeng Xia, Hui Ma, Jian Gao, Hongmei Yan, Yu Hu, Xiaoming Li, Qiqige Aleteng, Hua Bian and Wanyuan He. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.